urea has been researched along with Complication, Intraoperative in 20 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Excerpt | Relevance | Reference |
---|---|---|
"We report successful anesthetic management of a patient with pheochromocytoma using high-dose landiolol hydrochloride." | 7.80 | [Successful anesthetic management of a patient with giant pheochromocytoma using high-dose landiolol hydrochloride]. ( Kitano, M; Komasawa, N; Minami, T; Sawai, T, 2014) |
"The purpose of this study was to evaluate effects of landiolol hydrochloride, which is an ultra-short-acting beta-1 selective blocker, for intraoperative tachycardia and to establish practical methods of administration of the drug." | 7.78 | [Effect of landiolol hydrochloride for intraoperative tachycardia--multicenter questionnaire study]. ( Edanaga, M; Kirita, A; Koro, S; Kurihara, M; Mimura, M; Nakayama, Y; Ohsuda, M; Yamakage, M; Yamaya, K, 2012) |
"We report successful anesthetic management of elective cesarean section in a 30-year-old patient with Basedow disease using landiolol hydrochloride, a short-acting beta-1 adrenergic blocker of which greatest advantages are its short duration of action, rapid clearance and high beta-1 selectivity." | 7.76 | [Landiolol hydrochloride is useful for anesthetic management of cesarean section in a patient with Basedow disease]. ( Namiki, A; Namiki, M; Tsukakubo, T; Tsumura, N, 2010) |
" During the intraoperative discrepancy between heart rate and pulse rate, continuous infusion of low dose landiolol was useful to control his heart rate of atrial fibrillation." | 7.73 | [Effect of landiolol on heart rate control of atrial fibrillation in a patient with sick sinus syndrome under ventricular pacing]. ( Kitoh, T; Kobayashi, K; Otagiri, T; Satoh, N, 2006) |
"Landiolol (Onoact(®)) is an intravenously administered, ultra short-acting β1-blocker with an elimination half-life of 3-4 min and ≈8-fold greater cardioselectivity than esmolol in vitro." | 6.49 | Landiolol: a review of its use in intraoperative and postoperative tachyarrhythmias. ( Plosker, GL, 2013) |
"We report successful anesthetic management of a patient with pheochromocytoma using high-dose landiolol hydrochloride." | 3.80 | [Successful anesthetic management of a patient with giant pheochromocytoma using high-dose landiolol hydrochloride]. ( Kitano, M; Komasawa, N; Minami, T; Sawai, T, 2014) |
"The purpose of this study was to evaluate effects of landiolol hydrochloride, which is an ultra-short-acting beta-1 selective blocker, for intraoperative tachycardia and to establish practical methods of administration of the drug." | 3.78 | [Effect of landiolol hydrochloride for intraoperative tachycardia--multicenter questionnaire study]. ( Edanaga, M; Kirita, A; Koro, S; Kurihara, M; Mimura, M; Nakayama, Y; Ohsuda, M; Yamakage, M; Yamaya, K, 2012) |
"We report successful anesthetic management of elective cesarean section in a 30-year-old patient with Basedow disease using landiolol hydrochloride, a short-acting beta-1 adrenergic blocker of which greatest advantages are its short duration of action, rapid clearance and high beta-1 selectivity." | 3.76 | [Landiolol hydrochloride is useful for anesthetic management of cesarean section in a patient with Basedow disease]. ( Namiki, A; Namiki, M; Tsukakubo, T; Tsumura, N, 2010) |
" On the other hand, landiolol was effective for treating intraoperative hypertension and tachycardia." | 3.75 | [General anesthesia for cesarean section in a patient with moyamoya disease]. ( Asano, N; Ishiyama, T; Matsukawa, T; Sugihara, K, 2009) |
" Tachycardia of 140 beats x min(-1) persisted, and landiolol was continuously administered at a rate of 5-10 mg x hr(-1) after a 2." | 3.75 | [Case of thyroid crisis with persistent tachycardia diagnosed postoperatively]. ( Iijima, T; Iwao, Y; Kasuya, Y; Tamada, N; Yorozu, T, 2009) |
" During the intraoperative discrepancy between heart rate and pulse rate, continuous infusion of low dose landiolol was useful to control his heart rate of atrial fibrillation." | 3.73 | [Effect of landiolol on heart rate control of atrial fibrillation in a patient with sick sinus syndrome under ventricular pacing]. ( Kitoh, T; Kobayashi, K; Otagiri, T; Satoh, N, 2006) |
" Intravenous administration of an ultra short acting beta-blocker, landiolol hydrochloride, controlled heart rate and improved tachyarrhythmia without significant change of blood pressure." | 3.72 | [Successful treatment for tachyarrhythmia with ultra short acting beta-blocker during beating coronary artery bypass grafting; report of a case]. ( Fujii, G; Kasamatsu, M; Matsuura, A; Miyahara, K; Shimomura, T; Suzuki, S; Yoshida, K, 2004) |
"Landiolol (Onoact(®)) is an intravenously administered, ultra short-acting β1-blocker with an elimination half-life of 3-4 min and ≈8-fold greater cardioselectivity than esmolol in vitro." | 2.49 | Landiolol: a review of its use in intraoperative and postoperative tachyarrhythmias. ( Plosker, GL, 2013) |
"Intraoperative cerebral aneurysm rupture (IOR) is a common phenomenon with a frequency of around 19%." | 1.91 | Predictors of intraoperative intracranial aneurysm rupture in patients with subarachnoid hemorrhage: a retrospective analysis. ( Błoński, MJ; Frączek, MJ; Kliś, KM; Krzyżewski, RM; Kwinta, BM; Polak, J; Stachura, K, 2023) |
"Landiolol hydrochloride was administered continuously until the morning of the following day and sinus rhythm was maintained postoperatively." | 1.36 | Conversion of atrial flutter to sinus rhythm during landiolol infusion. ( Goto, K; Noguchi, T; Ohchi, Y; Shingu, C; Yamamoto, S; Yasuda, N, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (50.00) | 29.6817 |
2010's | 9 (45.00) | 24.3611 |
2020's | 1 (5.00) | 2.80 |
Authors | Studies |
---|---|
Frączek, MJ | 1 |
Błoński, MJ | 1 |
Kliś, KM | 1 |
Krzyżewski, RM | 1 |
Polak, J | 1 |
Stachura, K | 1 |
Kwinta, BM | 1 |
Plosker, GL | 1 |
Furuichi, Y | 1 |
Sakamoto, A | 2 |
Kitano, M | 1 |
Komasawa, N | 1 |
Sawai, T | 1 |
Minami, T | 1 |
Xiao, J | 1 |
He, P | 1 |
Zou, Q | 1 |
Zhao, Y | 1 |
Xue, Z | 1 |
Deng, X | 1 |
Li, S | 1 |
Guo, Q | 1 |
Tao, G | 1 |
Yang, T | 1 |
Lang, Z | 1 |
He, J | 1 |
Wang, X | 1 |
Hakone, M | 1 |
Yamada, T | 1 |
Motoyasu, A | 1 |
Kasuya, Y | 2 |
Yorozu, T | 2 |
Fujita, Y | 1 |
Shimizu, T | 1 |
Matsumoto, A | 1 |
Aoki, M | 1 |
Haase-Fielitz, A | 1 |
Bellomo, R | 1 |
Devarajan, P | 1 |
Story, D | 1 |
Matalanis, G | 1 |
Dragun, D | 1 |
Haase, M | 1 |
Asano, N | 1 |
Ishiyama, T | 1 |
Sugihara, K | 1 |
Matsukawa, T | 1 |
Yamamoto, S | 2 |
Goto, K | 2 |
Ohchi, Y | 1 |
Yasuda, N | 2 |
Shingu, C | 2 |
Noguchi, T | 2 |
Hagiwara, S | 1 |
Hidaka, S | 1 |
Kusaka, J | 1 |
Tamada, N | 1 |
Iijima, T | 1 |
Iwao, Y | 1 |
Namiki, M | 1 |
Tsumura, N | 1 |
Tsukakubo, T | 1 |
Namiki, A | 1 |
Ohsuda, M | 1 |
Edanaga, M | 1 |
Mimura, M | 1 |
Nakayama, Y | 1 |
Kirita, A | 1 |
Koro, S | 1 |
Yamaya, K | 1 |
Kurihara, M | 1 |
Yamakage, M | 1 |
Ogata, J | 1 |
Yokoyama, T | 1 |
Okamoto, T | 1 |
Minami, K | 1 |
Shimomura, T | 1 |
Fujii, G | 1 |
Suzuki, S | 1 |
Miyahara, K | 1 |
Matsuura, A | 1 |
Yoshida, K | 1 |
Kasamatsu, M | 1 |
Suzuki, Y | 1 |
Furuhashi, K | 1 |
Maruyama, K | 1 |
Yoshida, Y | 1 |
Hongo, T | 1 |
Ogawa, R | 1 |
Kinoshita, H | 1 |
Kakutani, T | 1 |
Mizumoto, K | 1 |
Hatano, Y | 1 |
Satoh, N | 1 |
Kobayashi, K | 1 |
Kitoh, T | 1 |
Otagiri, T | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Effects of Levosimendan on Renal Function in Patients With Low Ejection Fraction Undergoing Mitral Valve Surgery.[NCT01969071] | Phase 4 | 140 participants (Actual) | Interventional | 2009-07-31 | Completed | ||
Early Detection and Intervention of Acute Contrast Media Induced Nephropathy Using Neutrophil Gelatinase-associated Lipocalin (NGAL) May Improve Renal Outcome: A Study in Patients Undergoing Intra-arterial Angiography.[NCT01292317] | 819 participants (Actual) | Interventional | 2011-01-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for urea and Complication, Intraoperative
Article | Year |
---|---|
Landiolol: a review of its use in intraoperative and postoperative tachyarrhythmias.
Topics: Animals; Humans; Intraoperative Complications; Morpholines; Postoperative Complications; Randomized | 2013 |
[Perioperative cardiovascular evaluation and management for noncardiac surgery].
Topics: Adrenergic beta-Antagonists; Anesthesia; Atenolol; Bisoprolol; Fatty Acids, Monounsaturated; Fluvast | 2014 |
2 trials available for urea and Complication, Intraoperative
Article | Year |
---|---|
Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Blood Pressure; Double- | 2015 |
The effect of landiolol on cerebral blood flow in patients undergoing off-pump coronary artery bypass surgery.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Cerebrovascular Circulation; Coronary Artery Byp | 2010 |
16 other studies available for urea and Complication, Intraoperative
Article | Year |
---|---|
Predictors of intraoperative intracranial aneurysm rupture in patients with subarachnoid hemorrhage: a retrospective analysis.
Topics: Aneurysm, Ruptured; Glucose; Humans; Intracranial Aneurysm; Intraoperative Complications; Retrospect | 2023 |
[Successful anesthetic management of a patient with giant pheochromocytoma using high-dose landiolol hydrochloride].
Topics: Adrenal Gland Neoplasms; Analgesia, Epidural; Anesthesia, General; Arrhythmias, Cardiac; Catecholami | 2014 |
[Anesthetic Management of a Patient who Developed Intraoperative Paroxysmal Supraventricular Tachycardia with Pulseless Electric Activity].
Topics: Adrenergic beta-Antagonists; Aged; Anesthetics; Anti-Arrhythmia Agents; Electrocardiography; Female; | 2016 |
[Perioperative and postoperative management of two patients with uncontrolled hyperthyroidism using short acting beta blocker, landiolol].
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia; Antithyroid Agents; Fracture Fixation, Internal; Hum | 2008 |
Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery--a prospective cohort study.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Aged; Aged, 80 and over; Biomarkers; Cardiac Surgical Pro | 2009 |
Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery--a prospective cohort study.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Aged; Aged, 80 and over; Biomarkers; Cardiac Surgical Pro | 2009 |
Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery--a prospective cohort study.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Aged; Aged, 80 and over; Biomarkers; Cardiac Surgical Pro | 2009 |
Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery--a prospective cohort study.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Aged; Aged, 80 and over; Biomarkers; Cardiac Surgical Pro | 2009 |
[General anesthesia for cesarean section in a patient with moyamoya disease].
Topics: Adult; Anesthesia, General; Anesthesia, Obstetrical; Anti-Arrhythmia Agents; Cesarean Section; Emerg | 2009 |
Conversion of atrial flutter to sinus rhythm during landiolol infusion.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Hernia, Inguinal; Humans; Infusions, Intravenous; | 2010 |
[Case of thyroid crisis with persistent tachycardia diagnosed postoperatively].
Topics: Adult; Anti-Arrhythmia Agents; Emergencies; Fractures, Bone; Graves Disease; Humans; Intraoperative | 2009 |
[Landiolol hydrochloride is useful for anesthetic management of cesarean section in a patient with Basedow disease].
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthesia, Spina | 2010 |
[Effect of landiolol hydrochloride for intraoperative tachycardia--multicenter questionnaire study].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anesthesia, General; Female; Humans; Injections, Intraveno | 2012 |
Managing a tachyarrhythmia in a patient with pheochromocytoma with landiolol, a novel ultrashort-acting beta-adrenergic blocker.
Topics: Adrenal Gland Neoplasms; Adrenergic beta-Antagonists; Anesthesia; Anti-Arrhythmia Agents; Arrhythmia | 2003 |
[Successful treatment for tachyarrhythmia with ultra short acting beta-blocker during beating coronary artery bypass grafting; report of a case].
Topics: Adrenergic beta-Antagonists; Coronary Artery Bypass; Humans; Infusions, Intravenous; Intraoperative | 2004 |
[Clinical experience of landiolol for the treatment of intraoperative rapid atrial fibrillation].
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Cardiopulmonary Bypass; Cardiovascular Surgi | 2004 |
Successful management of tachycardiac atrial fibrillation in a septic patient with landiolol.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Hemodynamics; Humans; Intraoperative Complication | 2005 |
Effectiveness of bolus landiolol on paroxysmal atrial tachycardia.
Topics: Aged, 80 and over; Anesthesia, Spinal; Anti-Arrhythmia Agents; Bundle-Branch Block; Electrocardiogra | 2005 |
[Effect of landiolol on heart rate control of atrial fibrillation in a patient with sick sinus syndrome under ventricular pacing].
Topics: Anesthesia, General; Anti-Asthmatic Agents; Arthroplasty, Replacement; Atrial Fibrillation; Cardiac | 2006 |